Omnicell stock, healthcare technology

Omnicell stock trades 39.95 percent below its yearly high

Published on 09/25/2026 at 10:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Omnicell stock carries a fiscal 2026 consensus EPS estimate of USD 2.15 as of September 24, 2026. Second-quarter revenue reached USD 312.21 million, up 7.4 percent year over year.

Omnicell stock,  healthcare technology,  earnings growth,  analyst consensus,  Nasdaq, Illustration mit AI erstellt.
Omnicell stock, healthcare technology, earnings growth, analyst consensus, Nasdaq, Illustration mit AI erstellt.

Omnicell stock stood at USD 33.03 on Nasdaq on September 24, 2026, leaving the shares 39.95 percent below the 52-week high of USD 55.00. The valuation gap contrasts with fresh operating figures and a fiscal 2026 consensus EPS estimate of USD 2.15.

Revenue reaches USD 312.21 million

Omnicell reported second-quarter revenue of USD 312.21 million, up 7.4 percent from the prior-year quarter, according to MarketBeat. The same report cited quarterly EPS of USD 0.94 against a USD 0.47 consensus estimate, a USD 0.47 difference.

The comparison matters because the revenue increase was paired with an earnings beat rather than a sales-only improvement. Omnicell's latest quarterly financial data also show USD 32.449 million in operating profit and USD 24.289 million in net income for Q2 2026.

Consensus points to USD 2.15

Zacks reported on September 24, 2026, that the fiscal 2026 consensus estimate had risen to USD 2.15 per share after three analysts revised their forecasts higher during the prior 60 days. The estimate gives the stock a measurable earnings reference while the market price remains near the lower part of its yearly range.

Omnicell is pursuing a product refresh centered on Titan XT hardware and OmniSphere cloud software. At the Wells Fargo healthcare conference on September 9, 2026, management described a multi-year strategy while highlighting timing risk for large bookings, according to Investing.com.

Stock remains below USD 55.00

Omnicell's market capitalization was USD 1,502,168,067 on September 24, 2026. The Nasdaq quote ranged from USD 29.06 to USD 55.00 over the preceding 52 weeks, placing the USD 33.03 price closer to the yearly low than the yearly high.

Omnicell stock facts

  • Company: Omnicell, Inc.
  • Ticker: OMCL
  • Trading venue: Nasdaq
  • Price: USD 33.03 on September 24, 2026
  • Market capitalization: USD 1,502,168,067 as of September 24, 2026
  • 52-week range: USD 29.06-55.00
  • Sector / Industry: Healthcare / Medical Healthcare Information Services

Disclaimer...

en | boerse | 70182392 |